49 results on '"Morris, Robert A."'
Search Results
2. Occult residual ovarian tissue at the time of minimally invasive risk reducing surgery in women with BRCA mutations
3. Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study
4. Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
5. Comparing mutation frequencies for homologous recombination genes in uterine serous and high-grade serous ovarian carcinomas: A case for homologous recombination deficiency testing in uterine serous carcinoma
6. Molecular classification of endometrial carcinoma applied to endometrial biopsy specimens: Towards early personalized patient management
7. The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study
8. Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target
9. Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study
10. The prognostic significance of histologic type in early stage cervical cancer – A multi-institutional study
11. Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: A population-based analysis
12. Is the two-tier ovarian serous carcinoma grading system potentially useful in stratifying uterine serous carcinoma? A large multi-institutional analysis
13. Variability in Operative Experience Among US Gynecologic Oncology Fellows (030)
14. Transcriptomic immune profiling for cervical squamous cell carcinoma: Does HPV type matter? (170)
15. Molecular analysis of endometrioid and non-endometrioid uterine cancer and response to treatment (246)
16. The Genomic Landscape of Vulvovaginal Squamous Cell Carcinoma (048)
17. Molecular profiles of endometrial cancer tumors among Black patients
18. Clinical/pathologic features and patient outcome in early onset endometrial carcinoma: A population based analysis and an institutional perspective from the Detroit metropolitan area, Michigan
19. Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endometrial cancer
20. Intra-operative detection of nodal metastasis in early stage cervical cancer: A survey of the practice patterns of SGO members
21. Expression of GLUT-1 in epithelial ovarian carcinoma: Correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction
22. Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: An epidemiological analysis
23. Disparities in treatment and survival between African American and White women with vaginal cancer
24. The impact of race on survival in uterine serous carcinoma: A hospital-based study
25. Disease site matters: Ovarian carcinosarcoma has far more genomic similarity to high-grade serous ovarian carcinoma than to uterine carcinosarcoma
26. More than just low and high: A multi-omic analysis of gradations in loss of heterozygosity in high-grade serous ovarian cancer (181)
27. The cost of convenience: Fellow and program director perspectives on the adequacy of virtual fellowship interviews as a replacement for in-person interviews (2317)
28. Novel serum target for early detection of ovarian cancer (2303)
29. Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer (2295)
30. Randomized trial of interactive digital healthcare provider vs educational handout in HPV vaccine education: A pilot study (2164)
31. Exploring the nuances between BRCA1 and BRCA2: A multiomic analysis (1295)
32. Resection versus retention of the cervix at the time of hysterectomy with concurrent colorectal resection (1202)
33. Retrospective analysis of weekly topotecan as salvage therapy in relapsed ovarian cancer
34. Survival of women diagnosed with malignant, mixed mullerian tumors of the ovary (OMMMT)
35. Weekly topotecan in the management of ovarian cancer
36. Upper extremity deep vein thrombosis associated with indwelling peripheral venous catheters in gynecology oncology patients
37. Secondary Cytoreductive Surgery for Localized Intra-abdominal Recurrences in Epithelial Ovarian Cancer
38. Racial disparities in survival among patients with germ cell tumors of the ovary—United States
39. Second neoplasms in survivors of endometrial cancer: Impact of radiation therapy
40. A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study
41. Relative mortality in the women over 60 years of age with cervical cancer
42. Bladder erosion by an intraperitoneal chemotherapy catheter resulting in catheter protrusion through the external urethral meatus
43. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary
44. Topotecan weekly bolus chemotherapy for relapsed platinum-sensitive ovarian and peritoneal cancers
45. Attenuated titin protein expression correlates with poor prognosis in ovarian cancer.
46. Immature Teratomas of the Genital Tract in Older Women
47. Prevalence of targetable and potentially targetable alterations in metastatic/recurrent cervical cancer specimens in a large genomic dataset.
48. Supervised machine learning with a novel set of 20 genes predicts the likelihood of early or late recurrence of high-grade serous ovarian cancer.
49. Frequency and outcomes of co-mutations according to ProMisE classifiers in endometrial cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.